Winton Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Winton Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	$42.3M	Buy	814,610 +81,641	+11%	+$4.34M	0.29%	140
2013 Q4	$39M	Buy	732,969 +8,730	+1%	+$445K	0.35%	99
2013 Q3	$33.5M	Sell	724,239 -219,526	-23%	-$9.64M	0.4%	77
2013 Q2	$42.2M	Buy	+943,765	New	+$41M	0.51%	51

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Winton Capital Management's BMY Position: Q1 2014 in Review

Winton Capital Management increased its Bristol-Myers Squibb (BMY) stake by 11% in Q1 2014, buying an estimated $4.34M and bringing the position to 814,610 shares worth $42.3M. The position accounts for 0.29% of the portfolio, ranked #140.

Winton Capital Management first reported a position in BMY in Q2 2013 and has held it in 4 quarters since. 1,329 funds tracked by Wall St. Rank hold BMY as of Q1 2014.

Winton Capital Management held 814,610 shares of Bristol-Myers Squibb worth $42.3M as of Q1 2014.
Winton Capital Management bought 81,641 Bristol-Myers Squibb shares in Q1 2014, an estimated $4.34M.
Bristol-Myers Squibb made up 0.29% of Winton Capital Management's portfolio in Q1 2014, its #140 holding.
Winton Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 4 quarters since.
1,329 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2014.

Based on Winton Capital Management's 13F filing for Q1 2014, filed 1 May 2014.